Pharmacological Treatment of 22q11.2 Deletion Syndrome-related Psychoses-Reference-Cited by-同舟云学术

Pharmacological Treatment of 22q11.2 Deletion Syndrome-related Psychoses

Published:2015-06-19 Issue:06 Volume:48 Page:219-220
ISSN:0176-3679
Container-title:Pharmacopsychiatry
language:en
Short-container-title:Pharmacopsychiatry

Author:

Boot E.¹,Butcher N.²,Vorstman J.³,van Amelsvoort T.⁴,Fung W.¹,Bassett A.¹

Affiliation:

1. The Dalglish Family Hearts and Minds Clinic for Adults with 22q11.2 Deletion Syndrome, Toronto, Canada

2. Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto

3. Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands

4. Department of Psychiatry and Psychology, School of Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands

Publisher

Georg Thieme Verlag KG

Subject

Pharmacology (medical),Psychiatry and Mental health,General Medicine

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0035-1554645.pdf

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effectiveness and tolerability of pharmacotherapy for psychosis in 22q11.2 Deletion Syndrome: A systematic review;Australian & New Zealand Journal of Psychiatry;2024-02-21

2. Clozapine Use in 22q11.2 Deletion Syndrome;Journal of Clinical Psychopharmacology;2024-02-10

3. Efficacy and safety of clozapine in treatment-resistant psychotic patients with DiGeorge syndrome (22q11.2 deletion syndrome): a case series;International Clinical Psychopharmacology;2023-10-13

4. A case study of the utilization of clozapine treatment for treatment‐resistant schizophrenia associated with 22q11.2 deletion syndrome;Neuropsychopharmacology Reports;2023-03-16

5. Cognition- and circuit-based dysfunction in a mouse model of 22q11.2 microdeletion syndrome: effects of stress;Translational Psychiatry;2020-01-28